Rocket


News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Transition Therapeutics Inc. (TTHI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
09/13/2016 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
09/13/2016 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
09/09/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/31/2016 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
08/31/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/04/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Docs: "FORM 6-K",
"Notice of Special Meeting of Shareholders to be held August 25, 2016 and Notice of Application to the Ontario Superior Court of Justice (Commercial List) and Information Circular and Proxy Statement with respect to a Proposed Plan of Arrangement involving Transition Therapeutics Inc. and OPKO Health, Inc. and OPKO Global Holdings, Inc. and the Shareholders of Transition Therapeutics Inc."
07/13/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
07/06/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/30/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/03/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
05/09/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
04/26/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
03/24/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
02/17/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
02/12/2016 SC 13G/A FMR LLC reports a 14% stake in TRANSITION THERAPEUTICS INC
02/11/2016 SC 13D/A SCHULER JACK W reports a 18.8% stake in TRANSITION THERAPEUTICS INC.
02/05/2016 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
02/03/2016 SC 13G/A FEINBERG LARRY N reports a 10.8% stake in Transition Therapeutics, Inc.
09/15/2015 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
02/13/2015 SC 13G/A FMR LLC reports a 11.6% stake in TRANSITION THERAPEUTICS INC
02/12/2015 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
02/11/2015 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
01/30/2015 SC 13G/A FEINBERG LARRY N reports a 15.8% stake in Transition Therapeutics, Inc.
01/05/2015 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
09/25/2014 40-F Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
07/02/2014 SC 13D/A SCHULER JACK W reports a 20.7% stake in TRANSITION THERAPEUTICS INC.
03/07/2014 SC 13G PERRIGO Co plc reports a 7.1% stake in Transition Therapeutics Inc.
02/14/2014 SC 13G/A FMR LLC reports a 12.7% stake in TRANSITION THERAPEUTICS INC
02/07/2014 SC 13G/A FEINBERG LARRY N reports a 16% stake in Transition Therapeutics, Inc.
11/29/2013 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
09/11/2013 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
09/04/2013 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
08/22/2013 SC 13D/A SCHULER JACK W reports a 20.7% stake in TRANSITION THERAPEUTICS INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy